As Japan begins to enforce long-anticipated changes to its Pharmaceutical and Medical Device Act, it is ramping up penalties for violations of the new rules, which affect device registration, quality assurances, the regulation of medical software, and third-party certifications. But the changes... Read More
Background information Japan is the third-largest drug market in the world with a market size of about $95 billion in 2019. With about 30% of the population over 65 years old, it has a very large number of people who need drugs. Healthcare... Read More
In the wake of a 2019 antibiotic shortage which cast light on the country’s dependence on overseas suppliers of the essential drugs, Japan’s Ministry of Health, Labor and Welfare is proposing a series of measures to ensure stability in its supplies of... Read More
This article was originally published on Medtech Intelligence Some Asian countries are racing to ease import restrictions for needed goods that could save lives. Also, the Asian private sector is unveiling a raft of new artificial intelligence, telehealth and data privacy technologies,... Read More
With the COVID-19 pandemic cutting deeply into revenues of healthcare providers across Japan, health authorities are considering postponing cuts to prices for pharmaceuticals offered by the country’s nationalized health insurance system scheduled to go into effect next April. The scheduled price cuts... Read More
With cyber technologies occupying growing prominence in Japan’s health marketplace, the government has released guidance on protecting medical devices from computer network threats. The guidance from the Pharmaceutical and Medical Devices Agency (PMDA) does not impose new strictures on the manufacture,... Read More
Aging populations and increased incidences of chronic diseases across the Asia-Pacific region are spurring rapid growth in demand for in-vitro diagnostic (IVD) testing. That presents major marketing opportunities for the diagnostics industry in China, India, Southeast Asia, Japan, South Korea, and Indonesia. ... Read More
The COVID-19 pandemic is hampering the initiation and progress of clinical trials in Asia and around the world. Few patients are entering studies, and trials of new treatments are on hold. In Korea, the number of new patients enrolling in clinical... Read More
This article was originally published on MedTech Intelligence. With the COVID-19 pandemic shuttering physician offices and walk-in clinics, patients and doctors across Asian markets have turned increasingly to telehealth solutions. The surge is creating a short-term boom—and the likelihood of a long-term... Read More
https://attendee.gotowebinar.com/recording/5890292005019691021 Read More